These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26502767)

  • 21. Occupational determinants of cryptogenic polyneuropathy.
    Tondel M; Lindh J; Jonsson P; Vrethem M; Persson B
    Neuroepidemiology; 2006; 26(4):187-94. PubMed ID: 16569935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapy of polyneuropathies. Causal and symptomatic].
    Müller-Felber W
    MMW Fortschr Med; 2001 May; 143 Suppl 2():54-9. PubMed ID: 11434260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neuropathies and sensory neuropathies].
    Fernández JM; Mederer S
    Rev Neurol; 2000 Mar 16-31; 30(6):529-31. PubMed ID: 10863726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Alcoholic polyneuropathy. A clinical and electromyographic study].
    Hord ED
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1988; 33(4):283-93. PubMed ID: 2855549
    [No Abstract]   [Full Text] [Related]  

  • 25. An uncommon pattern of polyneuropathy induced by lifetime exposures to drift containing organophosphate pesticides.
    Ophir A; Karakis I; Richter ED; Abarbanel JM; Wormser U; Aschner M; Finkelstein Y
    Neurotoxicology; 2014 Dec; 45():338-46. PubMed ID: 25128617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Toxic polyneuropathies in shoe factories: preventive aspects].
    Carapella C
    Ann Ist Super Sanita; 1977; 13(1-2):353-65. PubMed ID: 603133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Polyneuropathies--symptoms, causes and diagnostic procedure].
    Neundörfer B
    Ther Umsch; 1993 Nov; 50(11):761-5. PubMed ID: 8191381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuromuscular ultrasound findings in polyneuropathy secondary to disulfiram.
    Stone SL; Cartwright MS; Panea OR; Vann RC; Magruder JL; Walker FO
    J Clin Neurophysiol; 2014 Dec; 31(6):e18-20. PubMed ID: 25462150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnosis and treatment of polyneuropathy: what can the family doctor do?].
    Hecht M; Heuss D; Hilz MJ
    MMW Fortschr Med; 2003 May; 145 Suppl 2():81-5. PubMed ID: 14579490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Peripheral nerves disorders under exposure to metallic mercury and complex of toxic chemicals].
    Rusanova DV; Lakhman OL
    Med Tr Prom Ekol; 2005; (12):28-32. PubMed ID: 16430119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partial conduction blocks in N-hexane neuropathy.
    Pastore C; Izura V; Marhuenda D; Prieto MJ; Roel J; Cardona A
    Muscle Nerve; 2002 Jul; 26(1):132-5. PubMed ID: 12115958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Declaration of Brescia on Prevention of the Neurotoxicity of Metals Brescia, Italia 17-18 June 2006.
    Landrigan P; Nordberg M; Lucchini R; Nordberg G; Grandjean P; Iregren A; Alessio L
    Med Lav; 2006; 97(6):811-4. PubMed ID: 17219773
    [No Abstract]   [Full Text] [Related]  

  • 33. [Toxic polyneuropathy].
    Melgaard B
    Ugeskr Laeger; 1977 Apr; 139(15):873-6. PubMed ID: 847826
    [No Abstract]   [Full Text] [Related]  

  • 34. Rate of neurotoxicant exposure determines morphologic manifestations of distal axonopathy.
    LoPachin RM; Lehning EJ; Opanashuk LA; Jortner BS
    Toxicol Appl Pharmacol; 2000 Sep; 167(2):75-86. PubMed ID: 10964758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Declaration of Brescia on prevention of the neurotoxicity of metals June 18, 2006.
    Landrigan P; Nordberg M; Lucchini R; Nordberg G; Grandjean P; Iregren A; Alessio L;
    Am J Ind Med; 2007 Oct; 50(10):709-11. PubMed ID: 17036364
    [No Abstract]   [Full Text] [Related]  

  • 36. [Polyneuropathies. Clinical aspects and experimental principles].
    Woelk H
    Fortschr Med; 1982 Oct; 100(37):1709-14. PubMed ID: 6184294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Polyneuropathy: diagnosis and management].
    Notermans NC; van Doorn PA
    Ned Tijdschr Geneeskd; 1997 Nov; 141(48):2327-33. PubMed ID: 9550822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Demyelinating polyneuropathies in patients with diabetes mellitus and chronic alcoholic intoxication].
    Kovrazhkina EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(5):41-5. PubMed ID: 22951780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison of electrophysiologic changes in persons with alcoholic polyneuropathy and polyneuropathy caused by carbon disulfide].
    Niewiadomska M; Piłkowska E; Wochnik-Dyjas D
    Neurol Neurochir Pol; 1986; 20(5):453-60. PubMed ID: 3587516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Exposure to organophosphate pesticides and peripheral polyneuropathy in workers from Maule Region, Chile].
    Grillo Pizarro Á; Achú Peralta E; Muñoz-Quezada MT; Lucero Mondaca B
    Rev Esp Salud Publica; 2018 Mar; 92():. PubMed ID: 29553128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.